Дмитренко, І.В. 2018. Prognostic value of early reduction of BCR/ABL1 gene expression in criteria of deep molecular response on imatynib therapy in patients with chronic myeloid leukemia. Problems of Environmental Biotechnology. 1 (Jun. 2018). DOI:https://doi.org/10.18372/2306-6407.1.12851.